Gabapentin, used to alleviate neuropathic pain in cancer patients, is administered in liquid form with a specific dosing schedule. Patients must gradually taper off the medication after treatment to avoid withdrawal symptoms, starting three weeks post-treatment with a structured plan. Common side effects include drowsiness, dizziness, and mood changes, while more serious reactions necessitate immediate medical attention.